Eotaxin expression and eosinophilic inflammation in asthma.
暂无分享,去创建一个
M. Stacey | A. Bellini | S. Mattoli | G. Sun | M. Marini | Martin A. Stacey | G. Sun
[1] J. Abrams,et al. Similar RANTES levels in healthy and asthmatic airways by immunoassay and in situ hybridization. , 1997, American journal of respiratory and critical care medicine.
[2] K. Chung,et al. Expression of RANTES mRNA and protein in airways of patients with mild asthma. , 1996, American journal of respiratory and critical care medicine.
[3] P. Forsythe,et al. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. , 1996, American journal of respiratory and critical care medicine.
[4] P. Leder,et al. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia , 1996, Nature Medicine.
[5] W Newman,et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. , 1996, The Journal of clinical investigation.
[6] H. Boushey,et al. Basic mechanisms of asthma. , 1995, Environmental health perspectives.
[7] A. Bellini,et al. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness. , 1994, Chest.
[8] J. Hsuan,et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation , 1994, The Journal of experimental medicine.
[9] B. Dewald,et al. Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.
[10] P. Murphy. The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.
[11] T. Williams,et al. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. , 1993, Biochemical and biophysical research communications.
[12] S. Mattoli,et al. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. , 1992, The Journal of allergy and clinical immunology.
[13] A. B. Kay,et al. Asthma and inflammation. , 1991, The Journal of allergy and clinical immunology.
[14] A J Wardlaw,et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. , 1991, The Journal of clinical investigation.
[15] M. Strath,et al. Eosinophilia in transgenic mice expressing interleukin 5 , 1990, The Journal of experimental medicine.
[16] J. Bousquet,et al. Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.
[17] G. Gleich. The eosinophil and bronchial asthma: current understanding. , 1990, The Journal of allergy and clinical immunology.
[18] N. Thomson,et al. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. , 1981, The Journal of allergy and clinical immunology.
[19] K Aas,et al. Heterogeneity of Bronchial Asthma , 1981, Allergy.